125 research outputs found
Application Of Multilayer Piezoelectric Elements For Resonant Cavity Deformation In VUV-FEL DESY Accelerator
Piezoelectric Stack Based System For Lorentz Force Compensation Caused By High Field In Superconducting Cavities
Dynamic Thermal Analysis of a Power Amplifier
This paper presents dynamic thermal analyses of a power amplifier. All the
investigations are based on the transient junction temperature measurements
performed during the circuit cooling process. The presented results include the
cooling curves, the structure functions, the thermal time constant distribution
and the Nyquist plot of the thermal impedance. The experiments carried out
demonstrated the influence of the contact resistance and the position of the
entire cooling assembly on the obtained results.Comment: Submitted on behalf of TIMA Editions
(http://irevues.inist.fr/tima-editions
Diagnostic Application for Development of Custom ATCA Carrier Board for LLRF
The Advanced Telecommunications Computing Architecture (ATCA) standard describes a powerful and efficient platform. With multiple integrated solutions like redundancies and intelligent control mechanisms this technology is characterized with reliability estimated at the level of 99.99999 percent. These features make the standard perfect for use in projects like the Free Electron Laser in Hamburg (FLASH) and the X-ray Free Electron Laser (X-FEL) in order to help them meet the requirements of high availability and reliability. The ATCA standard incorporates advanced control systems defined in the Intelligent Platform Management Interface (IPMI) specification as one of the key elements. The entire ATCA implementation retains its functionality as long as the IPMI remains operational. The complexity level of the application increases, which results in preparing it to run and debugging being more difficult to perform. At the same time, only scrupulous elimination of any kind of possible deficiencies can enable the ATCA implementation to offer the desired level of reliability. Thus, diagnostics become crucial, which creates a need for additional tools performing these tasks during the preparations of both hardware and software for the ATCA application. The paper presents application aiding in development of the prototype Carrier Board by enabling the user of external PC station to perform diagnostic and control activities over the Board. It helps in examining all its components at the stage of running the Board, as well as in further operation analysis
Smart Materials Based System Operated at 2K Used as a Superconducting Cavity Tuner for VUV-fel Purpose
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer
This prospective study was conducted with the Korean Cancer Study Group to evaluate the efficacy and safety of cetuximab combined with modified FOLFOX6 (mFOLFOX6) as first-line treatment in recurrent or metastatic gastric cancer and to identify potential predictive biomarkers. Patients received cetuximab 400 mg m−2 at week 1 and 250 mg m−2 weekly thereafter until disease progression. Oxaliplatin (100 mg m−2) and leucovorin (100 mg m−2) were administered as a 2-h infusion followed by a 46-h continuous infusion of 5-fluorouracil (2400 mg m−2) every 2 weeks for a maximum of 12 cycles. Biomarkers potentially associated with efficacy were analysed. Among 38 evaluable patients, confirmed response rate (RR) was 50.0% (95% CI 34.1–65.9). Median time-to-progression (TTP) was 5.5 months (95% CI 4.5–6.5) and overall survival (OS) 9.9 months. Eleven patients having tumour EGFR expression by immunohistochemistry with low serum EGF and TGF-α levels showed a 100% RR compared to 37.0% in the remaining 27 patients (P<0.001). Moreover, ligand level increased when disease progressed in seven out of eight patients with EGFR expression and low baseline ligand level. No patient exhibited EGFR amplification or K-ras mutations. Gastric cancer patients with EGFR expression and low ligand levels had better outcomes with cetuximab/mFOLFOX6 treatment
Clinical Potential of DNA Methylation in Gastric Cancer: A Meta-Analysis
Background: Accumulating evidence indicates aberrant DNA methylation is involved in gastric tumourigenesis, suggesting it may be a useful clinical biomarker for the disease. The aim of this study was to consolidate and summarize published data on the potential of methylation in gastric cancer (GC) risk prediction, prognostication and prediction of treatment response. Methods: Relevant studies were identified from PubMed using a systematic search approach. Results were summarized by meta-analysis. Mantel-Haenszel odds ratios were computed for each methylation event assuming the random-effects model. Results: A review of 589 retrieved publications identified 415 relevant articles, including 143 case-control studies on gene methylation of 142 individual genes in GC clinical samples. A total of 77 genes were significantly differentially methylated between tumour and normal gastric tissue from GC subjects, of which data on 62 was derived from single studies. Methylation of 15, 4 and 7 genes in normal gastric tissue, plasma and serum respectively was significantly different in frequency between GC and non-cancer subjects. A prognostic significance was reported for 18 genes and predictive significance was reported for p16 methylation, although many inconsistent findings were also observed. No bias due to assay, use of fixed tissue or CpG sites analysed was detected, however a slight bias towards publication of positive findings was observed
The Reelin Receptors Apoer2 and Vldlr Coordinate the Patterning of Purkinje Cell Topography in the Developing Mouse Cerebellum
The adult cerebellar cortex is comprised of reproducible arrays of transverse zones and parasagittal stripes of Purkinje cells. Adult stripes are created through the perinatal rostrocaudal dispersion of embryonic Purkinje cell clusters, triggered by signaling through the Reelin pathway. Reelin is secreted by neurons in the external granular layer and deep cerebellar nuclei and binds to two high affinity extracellular receptors on Purkinje cells-the Very low density lipoprotein receptor (Vldlr) and apolipoprotein E receptor 2 (Apoer2). In mice null for either Reelin or double null for Vldlr and Apoer2, Purkinje cell clusters fail to disperse. Here we report that animals null for either Vldlr or Apoer2 individually, exhibit specific and parasagittally-restricted Purkinje cell ectopias. For example, in mice lacking Apoer2 function immunostaining reveals ectopic Purkinje cells that are largely restricted to the zebrin II-immunonegative population of the anterior vermis. In contrast, mice null for Vldlr have a much larger population of ectopic Purkinje cells that includes members from both the zebrin II-immunonegative and -immunopositive phenotypes. HSP25 immunoreactivity reveals that in Vldlr null animals a large portion of zebrin II-immunopositive ectopic cells are probably destined to become stripes in the central zone (lobules VI–VII). A small population of ectopic zebrin II-immunonegative Purkinje cells is also observed in animals heterozygous for both receptors (Apoer2+/−: Vldlr+/−), but no ectopia is present in mice heterozygous for either receptor alone. These results indicate that Apoer2 and Vldlr coordinate the dispersal of distinct, but overlapping subsets of Purkinje cells in the developing cerebellum
Physiological roles for ecto-5’-nucleotidase (CD73)
Nucleotides and nucleosides influence nearly every aspect of physiology and pathophysiology. Extracellular nucleotides are metabolized through regulated phosphohydrolysis by a series of ecto-nucleotidases. The formation of extracellular adenosine from adenosine 5’-monophosphate is accomplished primarily through ecto-5’-nucleotidase (CD73), a glycosyl phosphatidylinositol-linked membrane protein found on the surface of a variety of cell types. Recent in vivo studies implicating CD73 in a number of tissue protective mechanisms have provided new insight into its regulation and function and have generated considerable interest. Here, we review contributions of CD73 to cell and tissue stress responses, with a particular emphasis on physiologic responses to regulated CD73 expression and function, as well as new findings utilizing Cd73-deficient animals
- …